Jason Mills

Stock Analyst at Canaccord Genuity

(3.89)
# 571
Out of 4,784 analysts
118
Total ratings
68.75%
Success rate
34.46%
Average return

Stocks Rated by Jason Mills

Penumbra
Feb 19, 2025
Maintains: Buy
Price Target: $323$340
Current: $267.56
Upside: +27.07%
TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $68.58
Upside: +58.94%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $17.79
Upside: +400.28%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $9.50
Upside: +194.74%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $105.00
Upside: +160.00%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $103.94
Upside: -47.08%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $3.77
Upside: +112.20%
Nevro
Aug 6, 2020
Maintains: Buy
Price Target: $116$153
Current: $5.84
Upside: +2,519.86%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $83.05
Upside: -63.88%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $491.84
Upside: -50.86%
Maintains: Hold
Price Target: $66$50
Current: $39.13
Upside: +27.78%
Maintains: Buy
Price Target: $41$45
Current: $31.83
Upside: +41.38%
Maintains: Buy
Price Target: $85$62
Current: $13.00
Upside: +376.92%
Maintains: Buy
Price Target: $43$46
Current: $99.36
Upside: -53.70%
Upgrades: Buy
Price Target: n/a
Current: $72.55
Upside: -